Amarin | AMRN - Interessi Passivi Sul Debito





Interessi Passivi Sul Debito Cambiamento Data
AbbVie USD 688M 58M 2026-09
Alnylam Pharmaceuticals USD -84.37M 166.42M 2026-09
Amarin USD 3K 5K 2024-12
AstraZeneca USD 371M 31M 2026-09
BioCryst Pharmaceuticals USD 21.71M 7.58M 2026-06
DBV Technologies USD 461K 323.71K 2025-03
GlaxoSmithKline GBP 219M 98M 2026-09
Halozyme Therapeutics USD 6.04M 457K 2026-09
Heron Therapeutics USD 600K 100K 2024-12
Ionis Pharmaceuticals USD 4M 14M 2026-09
Nektar Therapeutics USD 7.94M 1.83M 2026-03
Neurocrine Biosciences USD 300K 2.6M 2026-09
Novartis USD 468M 6M 2026-09